Trials / Completed
CompletedNCT05660694
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis: A Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Altamash Institute of Dental Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.
Detailed description
To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis. It was a randomized control clinical trial to compare efficacy of injection steroids versus pentoxifylline and vitamin E in the treatment of stage 2 and 3 OSF patient. Total 40 patients who presented with signs and symptoms of OSF were enrolled in our study that was evaluated over the period of (January 2020 to September 2021). Parameters taken in the study were age and mouth opening. Descriptive statistics and paired t-test were used for statistical analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone | Comparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy |
| DRUG | Pentoxifylline with Vitamin E | Comparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2022-12-21
- Last updated
- 2022-12-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05660694. Inclusion in this directory is not an endorsement.